Ishrat Aziz, Maria Anwar Khan, Saadat Ali


Background: Chronic obstructive pulmonary disease (COPD) is slowly progressing respiratory disease that leads to alveoli blockage and difficulty in breathing. The objective of this study was to determine the association of 1359 G/A polymorphism of central cannabinoid receptor 1 (CNR1) gene and chronic obstructive pulmonary disease in Pakistani population.

Materials & Methods: We investigated CNR1 single nucleotide polymorphism at the location 1359 G/A (p.Thr453Th; rs1049353) in 180 COPD patients and 194 healthy individuals In Department of Biology, Virtual University, Lahore, Pakistan in 2014-2015. DNA samples were extracted from venous leukocytes by using standard method, amplified (PCR) and digested (RFLP). Restriction digests were evaluated by 8% polyacrylamide gel. Frequencies of homozygous and heterozygous variants of 1359 G/A polymorphism were analyzed.

Results: Genotype distribution AA, GG, GA of CNR1 gene in COPD patients was 1.1%, 68.3% and 30.5% versus controls 3.1%, 56.0% and 40.8% respectively. The heterozygous genotype distribution (GA) was observed higher in patients 68.3% than controls 56%. Allele frequencies A and G of CNR1 gene were 0.311 and 0.688 in controls versus 0.353 and 0.646 in patients respectively. The A allele variant frequency was higher in patients 35.3% than controls 31.1%. Results indicated that polymorphism of CNR1 gene located at 1359 may have association with COPD disease.

Conclusions: Our study gave clue for association of COPD with 1359 G/A polymorphism of central cannabinoid receptor 1 (CNR1) gene in Pakistani population. Further studies are needed to elucidate the relationship of CNR1 gene to COPD by larger sample sizes.


Cannabinoid Receptor; Genes; Genotype; Chronic Obstructive Pulmonary Disease; Polymorphism; Single Nucleotide Polymorphism; Pakistan.

Full Text:



Agusti A, Vogelmeier C, Faner R. COPD 2020: changes and challenges. Am J Physiol Lung Cell Mol Physiol 2020 Nov 1;319(5):L879-83.

Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the aetiology of chronic bronchitis. Lancet 1965 Apr 10;1(7389):775-9.

Ali S, Khan MA, Aziz I. Molecular epidemiology of CNR1 gene in Pakistani healthy subjects in comparison with the healthy subjects from different countries of the world. Gomal Univ J Res 2017 Dec 29;33(2):18-25.

Piazza PV, Cota D, Marsicano G. The CB1 receptor as the cornerstone of exostasis. Neuron 2017;93(6):1252-74.

Bermudez-Silva FJ, Suarez J, Baixeras, E. Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia 2008;51:476-87.

Wright S. Cannabinoid-based medicines for neurological disorders-clinical evidence. Mol Neurbiol 2007 Aug;36(1):129-36.

Okpechi SC, Ghonim MA, Lammi RM. Advances in chronic obstructive pulmonary disease therapy: a vascular-targeted approach. Clin Med Insights: Therap 2017 Jun;9.

McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365(17):1567-75.

Sandford AJ. The BuMPy Road to COPD gene discovery. EBioMed 2016;5:18-9.

WHO. Chronic obstructive pulmonary disease (COPD) [uploaded 2022 May 20, accessed 2022 May 23]. Available at:

Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28(3):523-32.

Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. J Am Med As 2014;311(2):183-92.

WHO. WHO report on the global tobacco epidemic 2021: addressing new and emerging products [uploaded 2021 Jul 27, accessed 2022 May 23]. Available at:

Bossé Y. Updates on the COPD gene list. Int J Chron Obstruct Pulmon Dis 2012; 7:607-31.

Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N, et al. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet 2010;19(3):526-34.

Papatheodorou A, Makrythanasis P, Kaliakatsos M, Dimakou A, Orfanidou D, Roussos C, et al. Development of novel microarray methodology for the study of mutations in the SERPINA1 and ADRB2 genes-their association with obstructive pulmonary disease and disseminated bronchiectasis in Greek patients. Clin Biochem 2010;43(1-2):43-50.

Smolonska J, Wijmenga C, Postma DS, Boezen HM. Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. Am J Respir Crit Care Med 2009;180(7):618-31.

DeMeo DL, Hersh CP, Hoffman EA, Litonjua AA, Lazarus R, Sparrow D, et al. Genetic determinants of emphysema distribution in the national emphysema treatment wtrial. Am J Respir Crit Care Med 2007;176(1):42-8.

Cheng SL, Yu CJ, Chen CJ, Yang PC. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 2004;23(6):818-24.

Caenazzo L, Hoehe MR, Hsieh WT, Berrettini WH, Bonner TI, Gershon ES. HindIII identifies a two allele DNA polymorphism of the human cannabinoid receptor gene (CNR). Nucleic Acids Res 1991;19(17):47-98.

Gadzicki D, Muller K, Stuhrmann M. A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. Mol Cell Probes 1999;13(4):321-3.

Aziz I, Muzahir J, Jahangir A. Schizophrenia: From epidemiology to molecular epidemiology. Schizophr Bull 2015;41(1):133.

Miller SA, Dykes DD and Polesky HF: A simple salting out procedure for extraction DNA from human nucleated cells. Nucleic Acids Res 1988;16(3):1215.

Forey BA, Thornton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med 2011;11:36.

Vijayan VK. Chronic obstructive pulmonary disease. Indian J Med Res 2013; 137:251-69.

Nichter M, Nichter M, Van-Sickle, D. Popular perceptions of tobacco products and patterns of use among male college students in India. Soc Sci Med 2004;59(2):415-31.

Drope J. Key takeaways from the launch of the Tobacco Atlas 7th edition [uploaded 2022 May 18, accessed 2022 May 23]. Available at:

Yusuf MO. Systems for management of respiratory disease in primary care-an international series: Pakistan. Prim Care Respir J 2009;18(1):3-9.

Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence and future trends. Lancet 2007;370:765-73.

Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Sci 1999; 283(5400):401-4.

Leroy S, Griffon N, Bourdel M, Olie J, Poirier M, Krebs M. Schizophrenia and the cannabinoid receptor type 1 (CB1): Association study using a single-base polymorphism in coding exon 1. Am J Med Genet 2001;105(8):749-52.

Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M, et al. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Mol Psych 2002;7(5):515-8.

Jaeger JP, Mattevi SV, Callegari MS, Hutz HM. Cannabinoid type-1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population. Dis Mark 2008;25(1):67-74.

Isir AB, Nacak M, Balci SO, Pehlivan S, Kul S, Benlier N, et al. Relationship between the 1359 G/A polymorphism of the Central Cannabinoid Receptor 1 (CNR1) gene and susceptibility to cannabis addiction in a Turkish population. Aust J Forensic Sci 2014;47(2):230-8.

Storr M, Emmerdinger D, Diegelmann J, Pfennig S, Ochsenkühn T, Göke B, et al. The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. PloS One 2010;5(2):e9453.

De Luis DA, Ovalle HF, Soto GD, Izaola O, Fuente B, Romero E. Role of genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) on weight loss and cardiovascular risk factors after liraglutide treatment in obese patients with diabetes mellitus type 2. J Investig Med 2014;62(2):324-7.

Zuo L, Kranzler HR, Luo X, Covault J, Gelernter J. CNR1 variation modulates risk for drug and alcohol dependence. Biol Psych 2007;62(6):616-26.

Zammit S, Spurlock G, Williams H, Norton N, Williams N, O'Donovan MC. Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psych 2007;191:402-7.

Monteleone P, Bifulco M, Filippo C, Gazzerro P, Canestrelli B, Monteleone F, et al. Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects. Genes Brain Behav 2009;8(7):728-32.

Hu B, Wang Q, Chen Y, Du J, Zhu, X, Lu Y. Neuroprotective effect of WIN 55,212-2 pretreatment against focal cerebral ischemia through activation of extracellular signalregulated kinases in rats. Eur J Pharmacol 2010;645:102-7.



  • There are currently no refbacks.

Copyright (c) 2022. Ishrat Aziz, Maria Anwar Khan, Saadat Ali.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.